期刊文献+

早期静注倍他乐克治疗急性心肌梗死140例临床观察 被引量:3

Clinical observation of early intravenous injection with metoprolol in 140 patients with acute myocardial infarction
暂未订购
导出
摘要 目的观察早期静注倍他乐克治疗急性心肌梗死(AMI)的临床疗效。方法对已确诊的140例急性心肌梗死患者,按照倍他乐克的使用情况,随机分为试验组和对照组。两组入选后均常规给予尿激酶(uk)150万u静脉溶栓,低分子肝素(LMWH)、阿司匹林、硝酸甘油等综合治疗,其中两组均有30例行经皮冠状动脉介入干预(PCI)治疗。试验组入院后尽快给予静脉注射倍他乐克5mg(1mg/min),共3次,每次间隔5min,观察血压、心率的变化,总量15mg。静脉注射完成15min后,开始口服普通倍他乐克每6h 1次,每坎12.5~25mg,连续1个月、对照组入院后给予口服倍他乐克12.5~25mg每8h 1次,逐渐加量最大50mg/次。对两组疗效进行对照分析。结果试验组较对照组室性心律失常、室颤、心衰、再梗死率、ST段抬高持续天数、病死率的发生均显著下降(P〈0.01)。低血压、房室传导阻滞(A-VB)等并发症的发生率差异无显著性(P〉0.05)。结论早期静注倍他乐克可改善急性心肌梗死的预后。 Objective: To demonstrate the effect of early intravenous injection (i. v. )with metoprolol on patients with acute myocardial infarction {AMI). Methods 140 patients after AMI were randomly divided into the expcriment and control groups according to the treatment with metoprolol. The two groups were all treated with combined ther apy of urokinase, LMWA, aspirin and Nitroglycerin. There were 30 patients treated with PCI in each of the two groups. The experiment group received 5mg metoprolol i. v. as soon as possible after being hospitalized, all together three times in every 5 minutes with the total of 15mg. During the period, the change of blood pressure and hearl rate were carefully observed. Then the case group began oral application of metoprolol 12.5-25 mg q6h for one month after finishing with i. v. 15 mg metoprolot. The control group were treated with oral application of metoprolol 12.5 -25 mg q8h and gradually added to 50 mg every time. The effect of the two groups were analyzed with T-test after one month. Results There were significant decrease in the rate of venericular arrhythmia, vf, congestive heart failure, reinfarction,the persistent time of ST-segment elevating and fatality rate in the case group. There were no significant change in the rate of hypotension and A-V block in the two groups(T-test, P 〉 0.05). Conclusion Early treatment with metoprolol i.v. can improve the prognosis of patients with AMI.
出处 《泰山医学院学报》 CAS 2006年第2期117-119,共3页 Journal of Taishan Medical College
关键词 急性心肌梗死 倍他乐克 静脉注射 acute myocardial infarction( AM1) metoprolol intravenous injection
  • 相关文献

参考文献8

  • 1Gonzalez A,Garcia A,Jimenez F,et al.Heart rate variability during the 24 hours of myocardial infarction[J].Med Clin Barc,1998,31:81-85.
  • 2Francesco Borrello,Maribeth Beahan.Reappraisal of β-blocker therapy in the acute and chronic post-myocardial infarction period[J].Rev Cardiovasc Med,2003,14:13-24.
  • 3Cheorghiad M,Goldstein S.Beta-blockers in the post-myocardial infarction patient[J].Circulation.2002,106:394-398.
  • 4John C,Susan Ghaffari.Should everyone with a recent myocardial infarction receive a beta-blocker and an ACE inhibitor[J].Cleveland Clinic Journal of Medicine,2003,70:46-48.
  • 5ZhengH,HeBF,LuoRC.DiagnosticvalueofcombineddetectionofTPS,NSEandCEAinlungcancer[J].DiYiJunYiDaXueXueBao,2003,23(2)∶165.
  • 6黄峻.β受体阻滞剂在心血管疾病中的应用[A].见:黄峻.现代循证心脏病学[M].江苏:江苏省科学技术出版社,2002.684-702,371-378.
  • 7蒋立新.静脉β受体阻滞剂在心血管急症中的应用[J].中华心血管病杂志,2004,32(9):858-861. 被引量:91
  • 8马会利,方业民,马永利,冯军,王克强,葛均波.β受体阻滞剂对急性心肌梗死并发恶性心律失常的救治[J].第一军医大学学报,2004,24(4):475-476. 被引量:12

二级参考文献21

  • 1[1]β-Blocker Heart Attack Study Group. The β-blocker heart attack trail[J]. JAMA, 1981, 246: 2073-4.
  • 2[2]Viskin S, Kitzis I, Lev E, et al. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trails to clinical practice[J]. J Am Coll Cardiol, 1995, 25: 1327-32.
  • 3[3]Szabo BM, Crijms HJ, Wiesfeld AC, et al. Predicfors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function, importance of β-blockade[J]. Am Heart J, 1995, 130: 281-6.
  • 4[4]Scheinman MM, Levine JH, Cannom DS, et al. Doseranging study of intravenous amiodarone in patients with life-threatenning ventricular tachyarrhythmias[J]. Circulation, 1995, 92(11): 3264-72.
  • 5[5]Levine JH, Massumi A, Scheinman MM, et al. Intravenous amiodarone for recurrent sustained hypoteusive ventricular tachyarrhythmias[J]. J Am Coll Cardiol, 1996, 27(1): 67-75.
  • 6Barron HV,Rundle AC,Gore JM,et al.Intracranial hemorrhage rates and effect of immediate beta-blocker use in patients with acute myocardial infarction treated with tissue plasminogen activator.Participants in the National Registry of Myocardial Infarction-
  • 7Harjai KJ,Stone GW,Boura J,et al.Effects of prior beta-blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction.Am J Cardiol,2003,91:655-660.
  • 8Abrams J,Allen J,Allin D,et al.Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias:a multicenter double-blind clinical trial.Am Heart J,1985,110:913-922.
  • 9Mangano DT,Goldman L.Preoperative assessment of patients with known or suspected coronary disease.N Engl J Med,1995,333:1750-1756.
  • 10Poldermans D,Boersma E,Bax JJ,et al.The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery.Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Grou

共引文献101

同被引文献28

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部